Patent · US Expired

Use of HMG-COA reductase inhibitors to prevent and treat BPH

US6534537B2 · kind B2 · utility

2Cited by
1References
9Claims
0Family size

Inventors

Key dates

Filing dateJan 5, 2001
Grant dateMar 18, 2003
Priority date—
Expiry dateJan 5, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/4418
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of preventing and treating benign prostatic hypertrophy or benign prostatic hyperplasia wherein the method involves administering to a human or an animal a sufficient amount of a HMG Co-A Reductase Inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.